Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.85 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metacresol SCHEMBL29352064 | 0.92 | — | — | |
| Metacresol SCHEMBL10736 | 0.92 | — | — | |
| Metacresol SCHEMBL2314567 | 0.92 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL11437600 | 0.92 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL9774388 | 0.92 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL5533065 | 0.90 | — | — | |
| Metacresol SCHEMBL10008998 | 0.90 | ACHE (0.94) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL7177742 | 0.90 | — | — | |
| Metacresol SCHEMBL6234380 | 0.90 | ACHE (0.94) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL7177747 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558149-B1 | Epoxy resin and epoxy resin composition | SHELL INT RESEARCH (NL) | 1997-05-02 | — | — | EP | claimed |
| EP-0558149-A1 | Epoxy resin and epoxy resin composition | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-09-01 | — | — | EP | claimed |
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-1817318-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | Nippon Shokubai Co.,Ltd. (JP) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006080538-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-08-03 | — | — | WO | disclosed |
| US-5679856-A | OXYBROMINATION OF A PHENOL ETHER COMPOUND USING ELEMENTAL BROMINE IN THE PRESENCE OF HYDROGEN PEROXIDE AND A CATALYST; REACTING WITH FORMANILIDE | CIBA-GEIGY CORPORATION (US) | 1997-10-21 | — | — | US | disclosed |
| EP-0558149-B1 | Epoxy resin and epoxy resin composition | SHELL INT RESEARCH (NL) | 1997-05-02 | — | — | EP | disclosed |
| WO-1995019948-A1 | NOVEL ALKYL TETRALIN ALDEHYDE COMPOUNDS | UNION CAMP CORPORATION (US) | 1995-07-27 | — | — | WO | disclosed |
| US-5401720-A | Musk perfume | UNION CAMP CORPORATION (US) | 1995-03-28 | — | — | US | disclosed |
| WO-1995000114-A1 | TETRALINE® FORMATE ESTER AROMA CHEMICALS | UNION CAMP CORPORATION (US) | 1995-01-05 | — | — | WO | disclosed |
| US-5292719-A | Perfumes, colognes, soaps and cosmetics; musk aroma | UNION CAMP CORPORATION (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0558149-A1 | Epoxy resin and epoxy resin composition | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-09-01 | — | — | EP | disclosed |
| US-4146582-A | OXIDATION WITH A PERSULFATE AND A METALLIC SALT AS CATALYST | BRICHIMA S.P.A. (IT) | 1979-03-27 | — | — | US | disclosed |
| US-4111966-A | DYES FOR POLYESTERS | CIBA-GEIGY CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | AR, AHR, BCL6 | ACHE 4707/4885CYP1A2 909/4885CYP2C19 2009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.